Anxiety Disorder: symptoms and treatment. Do you have anxiety?

Conditions We Treat

Anxiety Disorders

Anxiety is a normal physiological response — until it isn’t. When fear circuits become persistently overactive, anxiety becomes a condition that disrupts daily life and responds to targeted clinical intervention.

Off-Label

rTMS for anxiety disorders is an off-label application in Australia, offered under psychiatrist oversight with full informed consent. Medicare rebates under MBS 14216 and MBS 14217 apply where anxiety is treated alongside TGA-approved treatment-resistant depression. All care is AHPRA-compliant.

Understanding the condition

What is an anxiety disorder?

Anxiety is a normal physiological response to perceived threat. The amygdala initiates a stress response, hormones prepare the body for action, and attention narrows to focus on the source of danger. In the short term, this is adaptive.

Anxiety becomes a disorder when the response is persistent, disproportionate to the actual threat, and causes significant interference with daily functioning. The brain’s fear circuits remain activated in the absence of genuine danger — producing the same physiological and psychological experience of threat, chronically and without resolution.

The result is a condition with measurable neurobiological underpinnings: dysregulation of the amygdala, prefrontal cortex, and the circuits connecting them. This is why evidence-based clinical intervention — not simply reassurance or willpower — is indicated.

Symptoms may include

Persistent worry or apprehension that is difficult to control

Physical symptoms: elevated heart rate, muscle tension, sweating, trembling

Avoidance of specific situations, places, or social interaction

Intrusive thoughts and compulsive behaviours (OCD)

Re-experiencing trauma, hypervigilance, emotional numbing (PTSD)

Restlessness, irritability, and difficulty concentrating

Recognised conditions

Types of anxiety disorders

Anxiety disorders differ from everyday anxiety in terms of intensity, persistence, and functional impact. In 2020–2022, more than one in six Australians aged 16–85 experienced an anxiety disorder in the previous 12 months — 3.4 million people. The conditions below are clinically recognised and assessed individually at Brain Aid Clinics.

01 Generalised Anxiety Disorder

Excessive, persistent worry across multiple domains of life — work, health, relationships — that is difficult to control and causes significant distress or functional impairment.

02 Generalised Anxiety Disorder

Excessive, persistent worry across multiple domains of life — work, health, relationships — that is difficult to control and causes significant distress or functional impairment.

03 Panic Disorder

Recurrent unexpected panic attacks — episodes of intense fear accompanied by physical symptoms including palpitations, shortness of breath, chest tightness, or dizziness — followed by persistent concern about future attacks.

04 OCD (Obsessive-Compulsive Disorder)

Recurrent intrusive thoughts (obsessions) and repetitive behaviours or mental acts performed to reduce associated distress (compulsions). The cycle is self-reinforcing and typically resistant to reassurance alone.

05 PTSD (Post-Traumatic Stress Disorder)

Symptoms arising after exposure to a traumatic event: intrusive re-experiencing, avoidance of reminders, negative alterations in cognition and mood, and heightened physiological arousal. Can become entrenched without targeted intervention.

06 Specific Phobias

Marked fear or avoidance of specific objects or situations — disproportionate to actual danger and causing significant distress or functional restriction.

Our approach

How Brain Aid Clinics treats anxiety

Management of anxiety disorders at Brain Aid Clinics is individually tailored following clinical assessment. No protocol is prescribed before we understand your specific presentation.

rTMS has an emerging evidence base for anxiety disorders. Low-frequency rTMS to the right dorsolateral prefrontal cortex (DLPFC) has demonstrated anxiolytic effects across multiple randomised controlled trials — calming overactive prefrontal-amygdala circuits that sustain the anxiety state. Protocol selection is individualised based on your symptom profile.

Anxiety and depression are highly comorbid — many patients present with both. Where this is the case, treatment protocols can be designed to address both dimensions within a single course, often producing better outcomes than treating each condition separately.

rTMS for anxiety disorders is an off-label application in Australia. It is offered under psychiatrist oversight with full informed consent. Medicare rebates under MBS 14216 and 14217 apply where anxiety is treated alongside TGA-approved treatment-resistant depression.

Psychological therapies

CBT, ACT, and exposure-based therapies address patterns of thought and avoidance. Evidence-based and effective for most anxiety presentations, particularly when combined with other interventions.

rTMS — neuromodulation

Direct modulation of the prefrontal-amygdala circuits that drive anxiety. Particularly relevant where anxiety has not responded adequately to medication or psychological therapy, or where comorbid depression is present.

Medication

Antidepressants (SSRIs, SNRIs) are first-line pharmacological options for most anxiety disorders. Prescribed and monitored by our psychiatrist, with decisions made individually based on history, risks, and response.

The TMF Programmeme

Thought, Movement, and Food. Regular physical activity, dietary quality, and sleep hygiene directly influence cortisol regulation and neuroinflammation — the biological systems that sustain anxiety. Integrated into every course of treatment.

Common Questions

What patients ask us

How is an anxiety disorder diagnosed?

Anxiety disorders result from the interaction of neurobiological, genetic, psychological, and environmental factors. Variations in amygdala reactivity and prefrontal regulatory function contribute to individual differences in anxiety vulnerability. Stressful life events, trauma, and chronic physiological stressors (poor sleep, inflammation, chronic pain) can precipitate or maintain anxiety disorders in predisposed individuals. The cause is rarely singular.

What causes anxiety disorders?

Diagnosis is made through a comprehensive clinical assessment by a qualified health professional using recognised criteria (DSM-5 or ICD-11), considering your individual history, symptoms, duration, and functional impact. Standardised screening tools may support the assessment. A diagnosis always reflects your unique circumstances — no two presentations are identical.

What treatment options are available?

Evidence-based options include psychological therapies (CBT, ACT, exposure-based approaches), antidepressant medication (SSRIs, SNRIs), and for appropriate presentations, rTMS. Lifestyle factors — physical activity, dietary quality, sleep — are clinically meaningful adjuncts, not merely lifestyle recommendations. Treatment is most effective when tailored to your specific presentation following thorough clinical assessment.

Can anxiety disorders be effectively managed?

Yes. With appropriate clinical assessment and treatment, the majority of people with anxiety disorders experience significant improvement. Response varies between individuals, between anxiety subtypes, and between treatment approaches. Achieving remission sometimes requires trialling more than one intervention, or combining approaches. The goal is a clinically meaningful reduction in symptoms and restoration of daily function — not simply managing the condition indefinitely.

Can lifestyle changes help with anxiety?

Yes, and through well-characterised biological mechanisms. Regular physical activity reduces amygdala reactivity and upregulates prefrontal inhibitory control. Dietary quality influences neuroinflammation and neurotransmitter production. Consistent sleep supports emotional regulation and reduces baseline cortisol. These are direct inputs into the neural systems that anxiety dysregulates — not peripheral additions to clinical care. At Brain Aid Clinics, the TMF Programmeme formalises these as part of every treatment course.

Who can diagnose and treat anxiety disorders?

GPs, psychiatrists, and psychologists are all qualified to diagnose and treat anxiety disorders. GPs are typically the first point of contact and can refer to psychiatrists for complex presentations or where specialist-level intervention (including rTMS) is being considered. At Brain Aid Clinics, assessment is psychiatrist-led, with treatment delivered within a multidisciplinary framework.

What should I expect at my first appointment at Brain Aid Clinics? +

Your first appointment is a clinical assessment — not a treatment session. Your treating clinician will review your history in detail: symptoms, duration, previous treatments, and what you’re hoping to achieve. If rTMS is clinically indicated, your eligibility is confirmed, any contraindications are assessed, and you receive a clear explanation of the protocol before you commit to anything. You leave with a clear clinical picture, not a sales pitch.

Clinical and regulatory note: rTMS for anxiety disorders is an off-label application in Australia, offered under psychiatrist oversight with full informed consent. rTMS is TGA-approved and Medicare-listed (MBS 14217) for treatment-resistant depression only. All information on this page is for general informational purposes and does not constitute medical advice. Please consult a qualified health professional regarding your individual circumstances. Brain Aid Clinics provides all care within AHPRA-compliant clinical and regulatory boundaries. ABN 76 664 676 420. If you are in crisis, contact Lifeline on 13 11 14.

Conditions We Treat